WHO welcomes report on efficacy of longer gaps between AstraZeneca doses

·1-min read
FILE PHOTO: Mass vaccination programme for Green Zone Tourism in Sanur, Bali

GENEVA (Reuters) - A report from Oxford University saying that a longer gap between doses of AstraZeneca vaccines still provides protection is "very reassuring" for supply-strapped countries, World Health Organization chief scientist Soumya Swaminathan said on Friday.

Joachim Hombach, head of the WHO's expert panel, said it was "great news" on spaced dosing for the vaccine, which would add flexibility to dosing schedules.

The Oxford study released this week found that the second dose can be delayed up to 45 weeks and still lead to an enhanced immune response.

(Reporting by Stepanie Nebehay; Writing by Giles Elgood, Editing by Louise Heavens)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting